Frontlight ResearchEarly access
Trial site
Axiom Clinical Research of Florida
- 3running trials
- 6closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Multiple sclerosis4 trials
- Mild cognitive impairment3 trials
- Phase
- Phase 37 trials
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- Novo Nordisk A/S2 trials
- Biogen1 trial
- Cognito Therapeutics, Inc.1 trial
- Eli Lilly and Company1 trial
- and 1 more
Running trials
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Closed trials
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026